VenatoRx Pharmaceuticals
Discovering and developing novel anti-infectives to treat multi-drug resistant bacterial and hard-to-treat viral infections. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$210m (Public information from Sep 2022)
Malvern Iowa (HQ)
Authorizing premium user...